MedTrace Logo

Long Term Results in Hypoplastic Aortic Arch Repair in Neonates Using a Glutaraldehyde Treated Autologous Pericardial Patch

NCT03588312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-07-23

No results posted yet for this study

Summary

Hypoplastic aortic arch is a congenital heart defect that is prejudicial for the growth of newborns. It is often associated to other heart defects. Different surgical techniques exist to address this defect, but the literature is very poor with regards to the use of an autologous pericardial patch. Most use extensive dissection techniques or synthetic patches. Here investigators report institution's original approach using the newborns own pericardium for what investigators believe to be an optimal correction of the hypoplasia., with preserved growth potential.

Conditions

  • Congenital Hypoplasia of Aortic Arch

Interventions

PROCEDURE

Aortoplasty using autologous pericardial patch

hypoplastic aortic arch repair using a glutaraldehyde treated, autologous pericardial patch.

Sponsors & Collaborators

  • Queen Fabiola Children's University Hospital

    lead OTHER

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-09-01
Completion
2018-09-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588312 on ClinicalTrials.gov